← Erland Erdmann

Papers by Erland Erdmann

Page 2 · newest first

51. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]European Heart Journal · 2006
52. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)European Heart Journal · 2006
53. Phosphodiesterase Type 5 Inhibition Is a Novel Therapeutic Option in Raynaud DiseaseArchives of Internal Medicine · 2006
54. Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite SequenceCirculation · 2005
55. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER surveyEuropean Heart Journal · 2005
56. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine · 2005
57. Diabetes and cardiovascular risk markersCurrent Medical Research and Opinion · 2005
58. Baseline Characteristics of Patients Recruited Into the CARE-HF StudyEuropean Journal of Heart Failure · 2005
59. The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)Diabetes Care · 2004
60. Effect of smoking on MAP kinase-induced modulation of IL‐8 in human alveolar macrophagesEuropean Respiratory Journal · 2004
61. Comparison of Treatment Initiation with Bisoprolol Vs. Enalapril in Chronic Heart Failure Patients: Rationale and Design of CIBIS-IIIEuropean Journal of Heart Failure · 2004
62. Use of NT-proBNP in Routine Testing and Comparison to BNPEuropean Journal of Heart Failure · 2004
63. Sildenafil Improved Pulmonary Hypertension and Peripheral Blood Flow in a Patient with Scleroderma-Associated Lung Fibrosis and the Raynaud PhenomenonAnnals of Internal Medicine · 2003
64. Mitogen-Activated Protein Kinase Modulation of Nuclear Factor-κB–Induced Granulocyte Macrophage–Colony-Stimulating Factor Release from Human Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology · 2003
65. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the “French paradox”The FASEB Journal · 2002
66. Cardiovascular events in patients with type 2 diabetesThe British Journal of Diabetes · 2002
67. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): Rationale, Design and End-PointsEuropean Journal of Heart Failure · 2001
68. Results From Post-Hoc Analyses of the CIBIS II Trial: Effect of Bisoprolol in High-Risk Patient Groups with Chronic Heart FailureEuropean Journal of Heart Failure · 2001
69. Thromboembolism in Heart Failure: who Should be Treated?European Journal of Heart Failure · 2000
70. Significance of Thromboembolism in Heart FailureEuropean Journal of Heart Failure · 2000
71. Reduced Sodium Pump α₁, α₃, and β₁-Isoform Protein Levels and Na⁺,K⁺-ATPase Activity but Unchanged Na⁺-Ca²⁺Exchanger Protein Levels in Human Heart FailureCirculation · 1999
72. cAMP‐Dependent Protein Kinase A‐Stimulated Sarcoplasmic Reticulum Function in Heart FailureaAnnals of the New York Academy of Sciences · 1998
73. A prognostic computer model to predict individual outcome in interventional cardiology: The INTERVENT ProjectEuropean Heart Journal · 1997
74. International Comparison of Awareness and Attitudes Towards Coronary Risk Factor Reduction: The HELP StudyEuropean Journal of Cardiovascular Prevention & Rehabilitation · 1997
75. Beta-blocking agents in heart failure Should they be used and how?European Heart Journal · 1996
76. Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart.Journal of Clinical Investigation · 1996
77. Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca ²⁺ Uptake and Ca ²⁺ -ATPase Activity of Cardiac Sarcoplasmic Reticulum From Dilated Cardiomyopathy Patients Compared With Patients With Nonfailing HeartsCirculation · 1995
78. Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and β-Adrenergic Signal TransductionCirculation · 1995
79. Treatment in Hypertensive Cardiac Hypertrophy, IHypertension · 1995
80. Treatment in Hypertensive Cardiac Hypertrophy, IIHypertension · 1995
81. Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.Hypertension · 1994
82. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardiumCardiovascular Research · 1994
83. The failing human heart is unable to use the Frank-Starling mechanism.Circulation Research · 1994
84. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart.Circulation Research · 1994
85. Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension.Hypertension · 1993
86. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure.Circulation Research · 1993
87. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure.Circulation Research · 1993
88. Adenosine receptors in the human heart: Pharmacological characterization in nondiseased and cardiomyopathic tissueDrug Development Research · 1993
89. Effects of exercise on myocardial adenylate cyclase and Gi alpha expression in senescenceAJP Heart and Circulatory Physiology · 1993
90. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.Circulation · 1993
91. CT and MR Evaluation of Pericardial ConstrictionJournal of Thoracic Imaging · 1993
92. Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivoAJP Heart and Circulatory Physiology · 1992
93. Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension.Hypertension · 1992
94. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.Circulation · 1992
95. Isolated presynaptic inotropic beta-adrenergic supersensitivity of the transplanted denervated human heart in vivo.Circulation · 1992
96. Ca2+ -currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium1992
97. Different β‐adrenoceptor‐effector coupling in human ventricular and atrial myocardiumEuropean Journal of Clinical Investigation · 1991
98. Failure of [32P]ADP-ribosylation by pertussis toxin to determine Giα content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducinBiochemical Journal · 1991
99. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.Circulation Research · 1991
100. Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.Circulation · 1990